Banque Transatlantique SA Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Banque Transatlantique SA acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 2,491 shares of the healthcare conglomerate's stock, valued at approximately $1,264,000.

Other institutional investors have also recently modified their holdings of the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $30,000. Finally, AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $30,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. HSBC reissued a "hold" rating and set a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday, April 22nd. JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Barclays cut their price target on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Finally, Oppenheimer dropped their price objective on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a report on Monday, April 21st. Four equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $596.86.

UnitedHealth Group Stock Performance

UNH stock opened at $398.72 on Friday. The business's fifty day simple moving average is $495.85 and its two-hundred day simple moving average is $528.45. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $362.92 billion, a price-to-earnings ratio of 25.72, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $393.11 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same period last year, the business posted $6.91 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.